Valion Bio VBIO
NASDAQ VBIO
$0.12 -0.01 (-7.69%)
At close: Aug 20, 2026 · 4:00 PM EDT

Valion Bio (VBIO) Receivables - Net (2021 - 2025)

Valion Bio (VBIO) posted quarterly Receivables - Net of $19000.0 for Q3 2025, up 111.11% year-over-year from $9000.0 in Q3 2024, and up 46.15% quarter-over-quarter from $13000.0 in Q2 2025.

Valion Bio (VBIO) Receivables - Net (2021 - 2025) Analysis & Trends

Valion Bio's Receivables - Net history runs 5 years deep, the most recent figure standing at $19000.0 for Q3 2025.

  • In Q3 2025, Receivables - Net rose 111.11% year-over-year to $19000.0; the TTM figure through Sep 2025 stood at $19000.0 (up 111.11% YoY), while the FY2024 annual figure was $69000.0, down 60.34% from the prior year.
  • Receivables - Net for Q3 2025 stood at $19000.0, up from $13000.0 in the prior quarter.
  • The five-year high for Receivables - Net was $174000.0 in Q4 2023, with the low at $9000.0 in Q3 2024.
  • The 5-year median for Receivables - Net is $71500.0 (2024), against an average of $68187.5.
  • The sharpest annual moves came in 2024 and 2025: Receivables - Net sank 93.13% in 2024, then soared 111.11% in 2025.
  • Valion Bio's Receivables - Net stood at $92000.0 in 2021, then rose by 16.3% to $107000.0 in 2022, then jumped by 62.62% to $174000.0 in 2023, then sank by 60.34% to $69000.0 in 2024, then slumped by 72.46% to $19000.0 in 2025.
  • Business Quant data shows VBIO's Receivables - Net at $19000.0 in Q3 2025, $13000.0 in Q2 2025, and $13000.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn
8 Royalty Pharma 26.98 Bn 26.14 Bn -
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn
10 Valion Bio 420,133.64 -1.78 Mn -45,000.00

Historic Data

Download Data
DateValue
Sep 30, 2025 19,000.00
Sep 30, 2025 19,000.00
Jun 30, 2025 13,000.00
Jun 30, 2025 13,000.00
Mar 31, 2025 13,000.00
Mar 31, 2025 13,000.00
Dec 31, 2024 69,000.00
Dec 31, 2024 69,000.00
Sep 30, 2024 9,000.00
Sep 30, 2024 9,000.00
Jun 30, 2024 16,000.00
Jun 30, 2024 16,000.00
Mar 31, 2024 74,000.00
Mar 31, 2024 74,000.00
Dec 31, 2023 174,000.00
Dec 31, 2023 174,000.00
Sep 30, 2023 131,000.00
Sep 30, 2023 131,000.00
Jun 30, 2023 13,000.00
Jun 30, 2023 13,000.00